Product Information
LIDOCAINE HCL 4% SOLUTION is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2220 per ML under NDC 51672141103. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Dec 7, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
40 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672141103
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218182FDA Approved
12/7/2023
TE Code
AT
On Market Since
12/8/2023
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 4% SOLUTION has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2220 per ML |
|---|---|
| All-time high | $0.3733 (Nov 13, 2024) |
| All-time low | $0.1999 (Jul 17, 2024) |
| 52-week high | $0.3584 |
| 52-week low | $0.2046 |
| Median price | $0.2693 |
| Average price | $0.2699 |
| Largest weekly change | +38.6% (Oct 23, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 4% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 4% SOLUTION, manufactured by Sun Pharmaceutical Industries Inc., is $0.2220 per ML (NDC 51672141103), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 4% SOLUTION changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 4% SOLUTION has declined 33.3%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 4% SOLUTION?
Since Apr 10, 2024, the NADAC for LIDOCAINE HCL 4% SOLUTION has ranged from a low of $0.1999 (Jul 17, 2024) to a high of $0.3733 (Nov 13, 2024), with a median of $0.2693 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 4% SOLUTION?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIDOCAINE HCL 4% SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE HCL 4% SOLUTION?
LIDOCAINE HCL 4% SOLUTION (NDC 51672141103) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.